Clinical Trial Update: Melatonin Dose-effect Relation in Childhood Autism [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dose–response of melatonin in childhood autism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Rennes University Hospital | Conditions: Childhood Autism | Phase 2 | Status: COMPLETED